Carbapenem resistance Overall survival Microbiota Nivolumab Brain injury Targeted therapy Alzheimer's disease Gene editing Biofilms Cutibacterium Propionibacterium acnes Tolerance Skin Fucosylation Lebanon Prognosis Clinical trial Anti-PD-1 ABO blood group Evolution Antibiotic resistance Metastatic melanoma France SARS-CoV-2 Screening Mycolactone Epidemiology Acinetobacter baumannii Bone and joint infection Erwinia amylovora Colonization Colorectal cancer Cystic fibrosis Primary care Elderly Anxiety Adoptive cell transfer Cationic lipids Faecalibacterium prausnitzii Acne COVID-19 Autoimmunity Immunology Diagnosis Analgesia Granuloma Infection Merkel cell carcinoma Truncal acne Cytotoxicity Circulating tumor DNA Buruli ulcer BRAF inhibitor Rotavirus Antimicrobial peptides Norovirus Antibodies Anti-CTLA-4 Abscess Prevention PD-1 Transplantation Antimicrobial resistance Case report Cancer Wood Adverse events Cutaneous squamous cell carcinoma Effectiveness FUT2 Amaranthin-like lectin Immunothérapie Dendritic cells Immune checkpoint inhibitors Cutibacterium acnes Mycobacterium ulcerans Breast cancer screening Bacteria Biofilm Animals Fucose Infective endocarditis Histo-blood group antigens Acinetobacter pittii Anti-PD1 Pembrolizumab General practitioners Genetic susceptibility Costimulation blockade Antimicrobial therapy Quality of life Glycans Immunotherapy Inflammation Public health Staphylococcus aureus Arabidopsis thaliana Biomarkers T cells Early detection of cancer Melanoma